Advanced Biomed Inc ADVB

US Health Care

$8.00 ▼ -20.63% ($-2.08)

⬇️ Below Yest. Low 🎈 Low Float

Open $9.65

Prev Close $10.08

Day Range $7.91 – $9.82

52W Range $3.61 – $24.23

Market Cap $13.22M

P/E (TTM) 3.15

Beta 0.99

EPS (TTM) $4.95

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2025-03-06
Shares Out.	1,650,000
Website	advanbiomed.com/ ↗
Phone	1862120510823
Employees	31
Net Income	-$488,942
Free Cash Flow	-$2.9M
Total Assets	$10.6M
Total Liabilities	$1.4M
Equity	$9.2M

About Advanced Biomed Inc

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Advanced Biomed Inc is a publicly traded company under the ticker symbol ADVB on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.